Stryker (SYK) Cash & Equivalents (2009 - 2026)

Stryker (SYK) has 18 years of Cash & Equivalents data on file, last reported at $2.9 billion in Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 24.05% year-over-year to $2.9 billion in Q1 2026; TTM through Mar 2026 was $2.9 billion, a 24.05% increase from a year earlier, with the FY2025 full-year figure at $4.0 billion, up 9.83% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $2.9 billion, down from $4.0 billion in the prior quarter.
• Over the last five years, Cash & Equivalents for SYK reached as high as $4.0 billion in Q4 2025 and fell as low as $1.0 billion in Q2 2022.
• Historically, Cash & Equivalents has averaged $2.4 billion across 5 years, with a median of $2.3 billion in 2025.
• Across the five-year window, Cash & Equivalents plunged 53.41% in 2022 and soared 106.99% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $1.8 billion in 2022, then soared by 61.12% to $3.0 billion in 2023, then rose by 22.92% to $3.7 billion in 2024, then advanced by 9.83% to $4.0 billion in 2025, then retreated by 28.25% to $2.9 billion in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $2.9 billion in Q1 2026, $4.0 billion in Q4 2025, and $3.3 billion in Q3 2025.